<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04533191</url>
  </required_header>
  <id_info>
    <org_study_id>IIT-001</org_study_id>
    <nct_id>NCT04533191</nct_id>
  </id_info>
  <brief_title>Binocular Custom Vision Utilizing The Light Adjustable Lens (LAL)</brief_title>
  <official_title>Binocular Custom Vision Utilizing The Light Adjustable Lens (LAL)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vance Thompson Vision</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vance Thompson Vision</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this investigator initiated study (IIT-001) is to obtain data on clinical&#xD;
      methods which can be used during the examination of patients desiring binocular custom vision&#xD;
      with the Light Adjustable Lens (LAL). An analysis of the collected data will be performed to&#xD;
      determine whether these clinical assessments can be used by doctors to enhance their&#xD;
      patient's clinical outcome.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2020</start_date>
  <completion_date type="Anticipated">February 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Binocular uncorrected distance, intermediate, and near visual acuity</measure>
    <time_frame>Through Month one post-op</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Binocular uncorrected depth of focus</measure>
    <time_frame>Through Month one post-op</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Manifest refraction</measure>
    <time_frame>Through Month one post-op</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Monocular uncorrected distance visual acuity</measure>
    <time_frame>Through Month one post-op</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Monocular best corrected distance visual acuity</measure>
    <time_frame>Through Month one post-op</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Satisfaction</measure>
    <time_frame>Through Month one post-op</time_frame>
    <description>Visual satisfaction will be obtained using a visual questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>4th order total eye spherical aberration (Z12)</measure>
    <time_frame>Through Month one post-op</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Cataract</condition>
  <condition>Pseudophakia</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Bilateral implantation of light adjustable intraocular lens and subsequent adjustment to binocular custom vision</intervention_name>
    <description>Subjects will receive bilateral implantation of a commercially available Light Adjustable Intraocular lens at the time of cataract surgery. Subsequently, they will undergo light adjustment of the lens to target binocular custom vision.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        A population of 25 patients who plan to undergo bilateral cataract surgery with&#xD;
        implantation of commercially available Light Adjustable Lens (LAL) and receive binocular&#xD;
        custom vision.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients able to sign informed consent&#xD;
&#xD;
          2. Patients who plan to undergo bilateral implantation with the commercial LAL and&#xD;
             receive binocular custom vision are eligible for study participation.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inability to sign informed consent&#xD;
&#xD;
          -  Any pathology for which, in the investigator's judgement, could reduce the subjects&#xD;
             BCVA&#xD;
&#xD;
          -  Unable to return for light treatments&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>110 Years</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Vance Thompson Vision</name>
      <address>
        <city>Sioux Falls</city>
        <state>South Dakota</state>
        <zip>57108</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Keeley Puls</last_name>
      <phone>605-371-7075</phone>
      <email>keeley.puls@vancethompsonvision.com</email>
    </contact>
    <contact_backup>
      <last_name>Kristin Dunne</last_name>
      <phone>6053613937</phone>
      <email>kristin.dunne@vancethompsonvision.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>August 25, 2020</study_first_submitted>
  <study_first_submitted_qc>August 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 31, 2020</study_first_posted>
  <last_update_submitted>October 5, 2020</last_update_submitted>
  <last_update_submitted_qc>October 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
    <mesh_term>Pseudophakia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

